Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Sarcopenia Physical Activity and Metabolomic
Authors not listed
Centre Hospitalier Universitaire de Nice · 2022
Abstract
Muscle failure (sarcopenia or dynapenia) is a factor of frailty and therefore, ultimately, of loss of autonomy in the elderly. Currently, no biomarker of muscle failure has a high sensitivity, specificity and positive predictive value. Several results, although preliminary, suggest that metabolomics could facilitate the early identification of frail patients, allowing the implementation of primary prevention strategies. Untargeted high-resolution metabolomics analysis would identify discriminative biomarkers and biological mechanisms associated with frailty. Finally, the hypothesis that metabolic signatures can be identified as risk factors for the development of age-related dynapenia should be tested in a longitudinal design.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2022). Sarcopenia Physical Activity and Metabolomic. <em>Centre Hospitalier Universitaire de Nice</em>. https://clinicaltrials.gov/study/NCT05199207
Vancouver
Anonymous. Sarcopenia Physical Activity and Metabolomic. Centre Hospitalier Universitaire de Nice. 2022.
BibTeX
@misc{anon2022Sarcop,
title = {Sarcopenia Physical Activity and Metabolomic},
author = {Anonymous},
journal = {Centre Hospitalier Universitaire de Nice},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization 2021
Open access · US-GOV
Comparison of the Swallowing Functions of the Sarcopenia and Dynapenia Patients
Hospices Civils de Lyon 2018
Open access · US-GOV
Impact of Physical Rehabilitation on Sarcopenia Inolder and Chronic Kidney Patients
Aarhus University Hospital 2020
Open access · US-GOV
Socioeconomic Factors and Mechanisms of Sarcopenia and Muscle Strength in Chronic Heart Failure Patients
Central South University 2024
Open access · US-GOV
Clinical Features and Possible Mechanisms in Patients With Sarcopenia in Parkinson's Disease
Journal of the American Heart Association 2024
Open access · CC-BY
Frailty and Cardiovascular Health
Anesthesia and Pain Medicine 2026
Open access · CC-BY